<p>，/PRNewswire/ -- 第 61 屆歐洲糖尿病研究協會年會（EASD 2025）在奧地利維也納成功舉行。在會議期間，三諾生物舉辦了國際行業研討會和專屬的網絡晚宴，充分展示了公司在糖尿病管理方面的專業知識。</p>
<p><strong>國際專家讚揚 iCan CGM 的卓越臨牀表現</strong></p>
<p>繼續閲讀</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/></p>
<p>洛裏·拉費爾教授</p>
<p>在 EASD 2025 開幕的週一，洛裏·拉費爾教授、吉多·弗雷克曼博士和朱莉亞·馬德爾教授受邀分享與 iCanTM CGM 合作的研究。研討會強調了 “表現、實用性和兒科” 這幾個關鍵主題，並展示了來自德國和美國的成人及兒童人羣的最新研究數據。此外，會議還提供了在實際環境中啓動 CGM 系統的見解，展示了來自領先兒科糖尿病中心的專業知識。討論還探討了糖尿病技術對熱愛飛行的糖尿病患者的旅行和就業機會的潛在影響。</p>
<p><strong>iCan i6 CGM 全球發佈：更智能的監測，提升的體驗</strong></p>
<p>下一代 iCan i6 CGM 系統成為三諾生物展位的焦點。除了 15 天的準確性和舒適的佩戴體驗，iCan i6 還提供多項用户體驗升級：一步應用，配備更小、更輕的傳感器；支持 27 種語言，全球可及性；內置高度補償算法，確保高海拔地區的可靠讀數；增強的移動應用集成，實現 “輕鬆監測和全球可及” 的體驗。</p>
<p>與此同時，三諾生物的獨家合作伙伴 A.Menarini Diagnostics s.r.l 在 EASD 展示了聯合品牌的 GlucoMen® iCan CGM 系統。Menarini 通過沉浸式展位體驗強調了 iCan 系統的最新功能和臨牀益處，吸引了現場醫療專業人士的強烈興趣和參與。</p>
<p><strong>從預防到管理：構建閉環糖尿病生態系統</strong></p>
<p>9 月 15 日，三諾生物舉辦了一場私人晚宴研討會，向關鍵合作伙伴揭示其新的 “A+C” 糖尿病預防與控制生態系統。該模型將 AGEscan 非侵入性篩查與 CGM 結合，以實現早期風險檢測和精準干預。三諾生物還介紹了其醫院血糖管理解決方案，能夠無縫連接門診和住院場景，實現端到端的數字糖尿病管理，提高效率和護理質量。</p>
<p>從前沿的 CGM 臨牀研究到綜合的預防和醫院管理解決方案，三諾生物在 EASD 2025 的參與加強了與專家和合作夥伴的全球合作，展示了其技術創新與患者和臨牀需求的深度融合。</p>
<p>來源：長沙三諾生物股份有限公司</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMDE1Jk5ld3NJdGVtSWQ9Q045ODM1MiZUcmFuc21pc3Npb25fSWQ9MjAyNTEwMTUwMjA3UFJfTkVXU19VU1BSX19fX19DTjk4MzUy?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMDE1Jk5ld3NJdGVtSWQ9Q045ODM1MiZUcmFuc21pc3Npb25fSWQ9MjAyNTEwMTUwMjA3UFJfTkVXU19VU1BSX19fX19DTjk4MzUy"/></p>

三諾生物

<p>三諾生物在 2025 年第 61 屆歐洲糖尿病研究協會年會上展示了其糖尿病管理解決方案。該公司舉辦了一場研討會，邀請國際專家討論 iCan CGM 的臨牀表現。新推出的 iCan i6 CGM 系統為用户提供了增強的功能。三諾生物還介紹了其 “A+C” 糖尿病預防與控制生態系統，將非侵入性篩查與 CGM 結合，實現早期風險檢測。此次活動強調了三諾生物在糖尿病護理領域對技術創新和全球合作的承諾</p>

<p>, /PRNewswire/ -- The 61st Annual Meeting of the European Association for the Study of Diabetes (EASD 2025) was successfully held in Vienna, Austria. During the conference, Sinocare hosted an international industry symposium and an exclusive networking dinner, fully demonstrating the company's professional expertise in diabetes management.</p>
<div class="lb-trans"><p>，/PRNewswire/ -- 第 61 屆歐洲糖尿病研究協會年會（EASD 2025）在奧地利維也納成功舉行。在會議期間，三諾生物舉辦了國際行業研討會和專屬的網絡晚宴，充分展示了公司在糖尿病管理方面的專業知識。</p>
</div><p><strong>International Experts Applaud iCan CGM's Exceptional Clinical Performance</strong></p>
<div class="lb-trans"><p><strong>國際專家讚揚 iCan CGM 的卓越臨牀表現</strong></p>
</div><p>Continue Reading</p>
<div class="lb-trans"><p>繼續閲讀</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null" alt="" original-src="https://www.prnewswire.com/news-releases/null"/></p>
<p>Professor Lori Laffel</p>
<div class="lb-trans"><p>洛裏·拉費爾教授</p>
</div><p>On the opening Monday of EASD 2025 in Vienna, Professor Lori Laffel, Dr. Guido Freckmann, and Professor Julia Mader were invited to share their researches collaborated with iCanTM CGM. The symposium highlighted key themes 'Performance, Practicality, and Pediatrics,' and presented promising data from recent German and U.S. studies involving both adult and pediatric populations. Additionally, the session provided insights into initiating CGM systems in real-world settings, featuring expertise from a leading pediatric diabetes center. The discussion also explored the potential impact of diabetes technology on travel and employment opportunities for individuals with diabetes who have a passion for flying.</p>
<div class="lb-trans"><p>在 EASD 2025 開幕的週一，洛裏·拉費爾教授、吉多·弗雷克曼博士和朱莉亞·馬德爾教授受邀分享與 iCanTM CGM 合作的研究。研討會強調了 “表現、實用性和兒科” 這幾個關鍵主題，並展示了來自德國和美國的成人及兒童人羣的最新研究數據。此外，會議還提供了在實際環境中啓動 CGM 系統的見解，展示了來自領先兒科糖尿病中心的專業知識。討論還探討了糖尿病技術對熱愛飛行的糖尿病患者的旅行和就業機會的潛在影響。</p>
</div><p><strong>Global Launch of iCan i6 CGM: Smarter Monitoring, Elevated Experience</strong></p>
<div class="lb-trans"><p><strong>iCan i6 CGM 全球發佈：更智能的監測，提升的體驗</strong></p>
</div><p>The next-generation iCan i6 CGM system was the centerpiece of attention in Sinocare's booth. Besides 15-day accuracy and comfortable wear, iCan i6 delivers multiple user experience upgrades: one-step application with a smaller, lighter sensor; 27-language support for global accessibility; built-in altitude compensation algorithm for reliable readings at high elevations; enhanced mobile app integration, enabling a &#34;effortless monitoring and globally accessible&#34; experience.</p>
<div class="lb-trans"><p>下一代 iCan i6 CGM 系統成為三諾生物展位的焦點。除了 15 天的準確性和舒適的佩戴體驗，iCan i6 還提供多項用户體驗升級：一步應用，配備更小、更輕的傳感器；支持 27 種語言，全球可及性；內置高度補償算法，確保高海拔地區的可靠讀數；增強的移動應用集成，實現 “輕鬆監測和全球可及” 的體驗。</p>
</div><p>At the same time, Sinocare's exclusive partner, A.Menarini Diagnostics s.r.l, showcased the co-branded GlucoMen® iCan CGM system at EASD. Menarini highlighted the iCan system's latest features and clinical benefits through an immersive booth experience, drawing strong interest and engagement from medical professionals on-site.</p>
<div class="lb-trans"><p>與此同時，三諾生物的獨家合作伙伴 A.Menarini Diagnostics s.r.l 在 EASD 展示了聯合品牌的 GlucoMen® iCan CGM 系統。Menarini 通過沉浸式展位體驗強調了 iCan 系統的最新功能和臨牀益處，吸引了現場醫療專業人士的強烈興趣和參與。</p>
</div><p><strong>From Prevention to Management: Building a Closed-Loop Diabetes Ecosystem</strong></p>
<div class="lb-trans"><p><strong>從預防到管理：構建閉環糖尿病生態系統</strong></p>
</div><p>On September 15, Sinocare hosted a private dinner seminar, unveiling its new &#34;A+C&#34; Diabetes Prevention and Control Ecosystem to key partners. This model integrates AGEscan non-invasive screening with CGM to enable early risk detection and precision intervention. Sinocare also introduced its hospital glucose management solution, which seamlessly connects outpatient and inpatient scenarios, achieving end-to-end digital diabetes management and improving both efficiency and quality of care.</p>
<div class="lb-trans"><p>9 月 15 日，三諾生物舉辦了一場私人晚宴研討會，向關鍵合作伙伴揭示其新的 “A+C” 糖尿病預防與控制生態系統。該模型將 AGEscan 非侵入性篩查與 CGM 結合，以實現早期風險檢測和精準干預。三諾生物還介紹了其醫院血糖管理解決方案，能夠無縫連接門診和住院場景，實現端到端的數字糖尿病管理，提高效率和護理質量。</p>
</div><p>From cutting-edge CGM clinical research to integrated prevention and hospital management solutions, Sinocare's presence at EASD 2025 strengthened global collaborations with experts and partners, and showcased its deep integration of technological innovation with patient and clinical needs.</p>
<div class="lb-trans"><p>從前沿的 CGM 臨牀研究到綜合的預防和醫院管理解決方案，三諾生物在 EASD 2025 的參與加強了與專家和合作夥伴的全球合作，展示了其技術創新與患者和臨牀需求的深度融合。</p>
</div><p>SOURCE Changsha Sinocare Inc.</p>
<div class="lb-trans"><p>來源：長沙三諾生物股份有限公司</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMDE1Jk5ld3NJdGVtSWQ9Q045ODM1MiZUcmFuc21pc3Npb25fSWQ9MjAyNTEwMTUwMjA3UFJfTkVXU19VU1BSX19fX19DTjk4MzUy" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=CN98352&amp;Transmission_Id=202510150207PR_NEWS_USPR_____CN98352&amp;DateId=20251015"/></p>

三諾生物在 EASD 展示其全面的糖尿病管理解決方案